ADGM
Adagio Medical Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.12
+18.08%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.10
From 52W high−92.83%
Volume3.16M
Market cap$3.21M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$0.10
From 52W high
−92.83%
Volume
3.16M
Market cap
$3.21M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.9x
P/E (TTM)
—
RSI (14)
25.4
MomentumView details →
1D Return
+18.08%
YTD Return
−89.54%
SummaryUpdated Jun 1, 2026
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) is a developmental stage medical device company founded in 2011 and headquartered in Laguna Hills, California. The company went public in July 2024 and specializes in developing advanced ablation technologies for treating cardiac arrhythmias, which are irregular heart rhythms that can be life-threatening if left untreated. Adagio focuses on innovative catheter-based solutions that use ultra-low temperature cryoablation and pulsed-field ablation techniques to restore normal heart rhythm in patients suffering from conditions like atrial fibrillation, atrial flutter, and ventricular tachycardia.
Similar companies
Latest newsMore news →
Adagio Medical Holdings, Inc. converted $776,111 aggregate principal amount of its 13% Senior Secured Convertible Notes into 4,978,869 shares of common stock under Section 3(a)(9) of the Securities Act.18d agoAdagio Medical Holdings, Inc. announced that its Board of Directors initiated a formal process to explore strategic alternatives aimed at maximizing shareholder value.27d ago